Cross-state causal comparison: identify key variables associated with state transitions
CHEN Yesheng1, WANG Ji2,3, ZHAO Tong4, WANG Huai-Yu2,3
1 School of Advanced Interdisciplinary Sciences, University of Chinese Academy of Sciences, Beijing 101408, China; 2 Wangqi Academy, Beijing University of Chinese Medicine, Beijing 100029, China; 3 National Institute of TCM Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing 100029, China; 4 School of Mathematical Sciences, University of Chinese Academy of Sciences, Beijing 100049, China
CHEN Yesheng, WANG Ji, ZHAO Tong, WANG Huai-Yu. Cross-state causal comparison: identify key variables associated with state transitions[J]. Journal of University of Chinese Academy of Sciences, DOI: 10.7523/j.ucas.2026.034.
[1] Brown M S, Goldstein J L.The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor[J]. Cell, 1997, 89(3): 331-340. DOI:10.1016/S0092-8674(00)80213-5. [2] Horton J D, Goldstein J L, Brown M S.SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver[J]. Journal of Clinical Investigation, 2002, 109(9): 1125-1131. DOI:10.1172/jci0215593. [3] Guerrero-Romero F, Simental-Mendía L E, González-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. comparison with the euglycemic-hyperinsulinemic clamp[J]. The Journal of Clinical Endocrinology & Metabolism, 2010, 95(7): 3347-3351. DOI:10.1210/jc.2010-0288. [4] Brown A E, Walker M.Genetics of insulin resistance and the metabolic syndrome[J]. Current Cardiology Reports, 2016, 18(8): 75. DOI:10.1007/s11886-016-0755-4. [5] Hotamisligil G S. Inflammation and metabolic disorders[J]. Nature, 2006, 444(7121): 860-867. DOI10.1038/nature05485. [6] Saltiel A R, Olefsky J M. Inflammatory mechanisms linking obesity and metabolic disease[J]. The Journal of Clinical Investigation, 2017, 127(1): 1-4. DOI10.1172/JCI92035. [7] Vaziri N D.Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences[J]. Kidney International, 2016, 90(1): 41-52. DOI:10.1016/j.kint.2016.02.026. [8] Agrawal S, Zaritsky J J, Fornoni A, et al.Dyslipidaemia in nephrotic syndrome: mechanisms and treatment[J]. Nature Reviews Nephrology, 2018, 14(1): 57-70. DOI:10.1038/nrneph.2017.155. [9] O’Neill S, O’Driscoll L. Metabolic syndrome: A closer look at the growing epidemic and its associated pathologies[J]. Obesity Reviews, 2015, 16(1): 1-12. DOI:10.1111/obr.12229.